Companies: 10,795·Total market cap: $144.5T
Affimed N.V.

Affimed N.V.

AFMDNASDAQHealthcare
$0.18
+$0.00(+0.00%)
Market Cap$2975612
P/E Ratio
52W High$8.95
52W Low$0.018
Overview

Affimed N.V.(AFMD)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · AFMD · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2023-122022-122021-122020-122019-12
Revenue
Revenue$8.28M$41.35M$40.37M$28.36M$21.39M
Cost of Revenue$0.00M$0.00M$0.00M$0.00M$0.00M
Gross Profit$8.28M$41.35M$40.37M$28.36M$21.39M
Gross Margin %(computed)100.00%100.00%100.00%100.00%100.00%
Operating Expenses
R&D Expenses$94.96M$98.81M$81.49M$49.99M$43.79M
G&A Expenses$24.68M$32.08M$24.22M$13.71M$10.27M
Total Operating Expenses$114.94M$130.89M$105.71M$63.70M$54.04M
Operating Income($106.66M)($88.12M)($64.03M)($34.72M)($32.38M)
Operating Margin %(computed)-213.09%-158.62%-122.42%-151.35%
Interest Income$0.51M$0.36M($0.41M)$0.19M$0.60M
Interest Expense$1.81M$1.63M$0.71M$0.10M$0.48M
Income Before Tax($105.94M)($86.00M)($57.52M)($41.37M)($32.36M)
Income Tax Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Net Income($105.94M)($86.00M)($57.52M)($41.37M)($32.37M)
Net Margin %(computed)-207.98%-142.50%-145.86%-151.30%
Per Share & EBITDA
EPS (Basic)$-7.09$-6.04$-4.81$-4.96$-5.04
Wtd Avg Shares14.94M14.24M11.95M8.35M6.42M
EBITDA($102.38M)($81.47M)($55.42M)($40.23M)($30.97M)
EBITDA Margin %(computed)-197.02%-137.30%-141.86%-144.79%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · EUR · M

深入了解Affimed N.V.

关于Affimed N.V.(AFMD)损益表

Affimed N.V.(AFMD)损益表数据来源于SEC Form 10-K及10-Q申报文件。2023财年,AFMD实现营收$0.01B,毛利润$0.01B(毛利率100.00%),净利润($0.11B)(净利率-1280.22%)。

常见问题

AFMD · 4 问

Affimed N.V.(AFMD)2023财年营收为$0.01B,同比down80.0%。

AFMD revenueAFMD salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09